Safety and Pharmacovigilance
Ensuring safety through all stages of clinical development
Safety monitoring services tailored precisely to your needs
Overview
Biotech companies have specific and demanding clinical safety requirements. Because we’re Built for Biotech℠, our consultants and specialists design safety and pharmacovigilance services that exactly fit your product’s and study’s needs – and we’re agile and flexible enough to adapt as they do.
Study-Specific Services
We manage the clinical safety process from triage through case processing, narrative writing, and submission to competent authorities and ethics committees, supported by a comprehensive framework of standard operating procedures (SOPs) and study-specific safety plans. Our services include:
- Medical triage of serious adverse events
- Case processing
- Narrative writing
- Medical review and assessment
- Risk/benefit assessments
- Submissions to competent authorities, ethics committees, and sites
- Development safety update report writing
- Signal detection
Portfolio Services
Many of our biotech customers start with a safety database at the study level and later decide to invest in a global safety database. By pooling all the safety data into one safety database and one dataset, we can better optimize signal detection and risk/benefit assessments. The Premier Consulting team can manage the migration of all your portfolio safety data into a dedicated global safety database while maintaining and archiving your data for as long as needed.
Consulting Services
Even the best safety team can benefit from additional support, so Premier Consulting’s pharmacovigilance consultants and specialists work with our regulatory and medical writing teams to provide flexible solutions for short-term and limited-scope services, including:
- Aggregate report writing
- PV SOP and procedure writing
- Risk management plans
- Literature searches and reports
- Inspection readiness audits
- Preparation of reference safety information
- Risk/benefit statements
- Medical review of individual case study reports
- Signal detection
- General consulting and regulatory advice
Insights
Agility and knowledge at your fingertips
Safety, Efficacy, Cost: The Trifecta for Increasing Access to CAR-T Therapies
ANDA or 505(b)(2): Choosing the Right Abbreviated Approval Pathway for Your Drug
resources
Stay ahead of the curve by browsing our extensive library of white papers, case studies, blog posts, and more.
Ready to get started? So are we.
Drop us a line to learn more about how we can help.